Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
ImmunityBio, Inc.
Business Segments
Business Segments
R&D
R&D
ImmunityBio, Inc.
·
Business Segments
·
1 segment
·
Rolls up to
R&D
Breakdown
Segments
Reportable Segment
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Reportable Segment
$48.23M
$55.24M
$51.23M
$63.86M
$67.99M
Total
—
—
—
—
—